Ghorbanzadeh V, Mohammadi M, Dariushnejad H, Chodari L, Mohaddes G
Drug Applied Research Center of Tabriz University of Medical Sciences, Tabriz, Iran.
Neuroscience Research Centre of Tabriz University of Medical Sciences, 5166614766, Tabriz, Iran.
J Endocrinol Invest. 2016 Oct;39(10):1179-86. doi: 10.1007/s40618-016-0456-2. Epub 2016 Apr 19.
Hyperglycemia is the main risk factor for microvascular complications in type 2 diabetes. Crocin and voluntary exercise have anti-hyperglycemic effects in diabetes. In this research, we evaluated the effects of crocin and voluntary exercise alone or combined on glycemia control and heart level of VEGF-A.
Animals were divided into eight groups as: control (con), diabetes (Dia), crocin (Cro), voluntary exercise (Exe), crocin and voluntary exercise (Cro-Exe), diabetic-crocin (Dia-Cro), diabetic-voluntary exercise (Dia-Exe), diabetic-crocin-voluntary exercise (Dia-Cro-Exe). Type 2 diabetes was induced by a high-fat diet (4 weeks) and injection of streptozotocin (STZ) (i.p, 35 mg/kg). Animals received oral administration of crocin (50 mg/kg) or performed voluntary exercise alone or together for 8 weeks. Oral glucose tolerance test (OGTT) was performed on overnight fasted control, diabetic and treated rats after 8 weeks of treatment. Then, serum insulin and heart VEGF-A protein levels were measured.
Crocin combined with voluntary exercise significantly decreased blood glucose levels (p < 0.001) and insulin resistance (HOMA-IR) (p < 0.001) compared to diabetic group. VEGF-A level was significantly (p < 0.01) lower in Dia group compared to control group. The combination of crocin and voluntary exercise significantly enhanced VEGF-A protein levels in Dia-Cro-Exe and Cro-Exe group compared to diabetic and control groups, respectively; p < 0.001 and p < 0.05.
Crocin combined with voluntary exercise improved insulin resistance (HOMA-IR) and reduced glucose levels in diabetic rats. Since both crocin and voluntary exercise can increase VEGF-A protein expression in heart tissue, they probably are able to increase angiogenesis in diabetic animals.
高血糖是2型糖尿病微血管并发症的主要危险因素。藏红花素和自主运动对糖尿病具有降血糖作用。在本研究中,我们评估了单独使用藏红花素和自主运动或两者联合使用对血糖控制及心脏中血管内皮生长因子A(VEGF-A)水平的影响。
将动物分为八组:对照组(con)、糖尿病组(Dia)、藏红花素组(Cro)、自主运动组(Exe)、藏红花素与自主运动组(Cro-Exe)、糖尿病-藏红花素组(Dia-Cro)、糖尿病-自主运动组(Dia-Exe)、糖尿病-藏红花素-自主运动组(Dia-Cro-Exe)。通过高脂饮食(4周)和腹腔注射链脲佐菌素(STZ)(35mg/kg)诱导2型糖尿病。动物单独或联合接受藏红花素口服给药(50mg/kg)或进行自主运动,持续8周。治疗8周后,对过夜禁食的对照、糖尿病及治疗大鼠进行口服葡萄糖耐量试验(OGTT)。然后,检测血清胰岛素和心脏VEGF-A蛋白水平。
与糖尿病组相比,藏红花素与自主运动联合使用显著降低血糖水平(p<0.001)和胰岛素抵抗(HOMA-IR)(p<0.001)。与对照组相比,糖尿病组的VEGF-A水平显著降低(p<0.01)。与糖尿病组和对照组相比,藏红花素与自主运动联合使用分别显著提高了Dia-Cro-Exe组和Cro-Exe组的VEGF-A蛋白水平;p<0.001和p<0.05。
藏红花素与自主运动联合使用可改善糖尿病大鼠的胰岛素抵抗(HOMA-IR)并降低血糖水平。由于藏红花素和自主运动均可增加心脏组织中VEGF-A蛋白的表达,它们可能能够促进糖尿病动物的血管生成。